Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

574 ARTÍCULOS , VIENDO DEL 256 AL 270

Neuroprotective potential of berberine in modulating Alzheimer's disease via multiple signaling pathways

Akbar M, Shabbir A, Rehman K, Akash MSH, Shah MA.

J Food Biochem. 2021 Oct;45(10):e13936. doi: 10.1111/jfbc.13936. Epub 2021 Sep 14.

The Beneficial Role of Natural Endocrine Disruptors: Phytoestrogens in Alzheimer's Disease

Domańska A, Orzechowski A, Litwiniuk A, Kalisz M, Bik W, Baranowska-Bik A.

Oxid Med Cell Longev. 2021 Sep 3;2021:3961445. doi: 10.1155/2021/3961445. eCollection 2021.

Safe and Effective Disease-Modifying Therapies for Small Blood Vessel Disease in the Brain

Arboleda-Velasquez JF.

Am J Pathol. 2021 Nov;191(11):1852-1855. doi: 10.1016/j.ajpath.2021.09.003. Epub 2021 Sep 14.

Cannabinoids for the treatment of dementia

Bosnjak Kuharic D, Markovic D, Brkovic T, Jeric Kegalj M, Rubic Z, Vuica Vukasovic A, Jeroncic A, Puljak L.

Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2.

Can we learn lessons from the FDA's approval of aducanumab?

Liu KY, Howard R.

Nat Rev Neurol. 2021 Nov;17(11):715-722. doi: 10.1038/s41582-021-00557-x. Epub 2021 Sep 17.

Cognitive Heterogeneity in Alzheimer Clinical Trials: Harnessing Noise to Achieve Meaningfulness

Buckley RF, Knopman DS.

Neurology. 2021 Jun 1;96(22):1017-1018. doi: 10.1212/WNL.0000000000012027.

Autophagy in Alzheimer's disease pathogenesis: Therapeutic potential and future perspectives

Zhang Z, Yang X, Song YQ, Tu J.

Ageing Res Rev. 2021 Dec;72:101464. doi: 10.1016/j.arr.2021.101464. Epub 2021 Sep 20.

Neuroprotective Potential of Mung Bean (Vigna radiata L.) Polyphenols in Alzheimer's Disease: A Review

Xu H, Zhou Q, Liu B, Cheng KW, Chen F, Wang M.

J Agric Food Chem. 2021 Oct 6;69(39):11554-11571. doi: 10.1021/acs.jafc.1c04049. Epub 2021 Sep 22.

GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH

Li QX, Gao H, Guo YX, Wang BY, Hua RX, Gao L, Shang HW, Lu X, Xu JD.

Front Endocrinol (Lausanne). 2021 Sep 6;12:721198. doi: 10.3389/fendo.2021.721198. eCollection 2021.

Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide

Sharma HS, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Sahib S, Tian ZR, Bryukhovetskiy I, Manzhulo I, Menon PK, Patnaik R, Wiklund L, Sharma A.

Prog Brain Res. 2021;265:1-97. doi: 10.1016/bs.pbr.2021.04.008. Epub 2021 Aug 12.

Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer's Disease

Roland JP, Bliwise DL.

Drugs Aging. 2021 Nov;38(11):951-966. doi: 10.1007/s40266-021-00891-1. Epub 2021 Sep 27.

The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer's Disease

Golzari-Sorkheh M, Brown CE, Weaver DF, Reed MA.

J Alzheimers Dis. 2021;84(2):579-598. doi: 10.3233/JAD-210660.

Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer's Disease

Wang Q, Dong X, Zhang R, Zhao C.

J Alzheimers Dis. 2021;84(2):505-533. doi: 10.3233/JAD-210735.

Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial

Vossel K, Ranasinghe KG, Beagle AJ, La A, Ah Pook K, Castro M, Mizuiri D, Honma SM, Venkateswaran N, Koestler M, Zhang W, Mucke L, Howell MJ, Possin KL, Kramer JH, Boxer AL, Miller BL, Nagarajan SS, Kirsch HE.

JAMA Neurol. 2021 Nov 1;78(11):1345-1354. doi: 10.1001/jamaneurol.2021.3310.

Therapeutic Potential of Human Stem Cell Implantation in Alzheimer's Disease

Chan HJ, Yanshree, Roy J, Tipoe GL, Fung ML, Lim LW.

Int J Mol Sci. 2021 Sep 21;22(18):10151. doi: 10.3390/ijms221810151.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias